Search clinical trials for: Serotonin 5-HT4 Receptor Agonists

Total 7245 results

H. Lundbeck A/S

Completed

Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression (VIVRE)

Major Depressive Disorder

Spain, Czechia, Slovakia, Estonia, Sweden, Argentina, Belgium, Bulgaria, Latvia, Mexico, Russian Federation, Ukraine
Novartis

Completed

Efficacy and Safety of BGG492 in the Treatment of Migraine

Migraine

Germany, Spain, United States
Zosano Pharma Corporation

Completed

Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine (Zotrip)

Acute Migraine

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Sumatriptan 100mg Tablets Under Fasting Conditions

Healthy

India
Zogenix, Inc.

Completed

A Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine Attack

Migraine Headache

United States
Pfizer

Completed

A STUDY TO EVALUATE THE EFFECT OF PF-06651600 ON PHARMACOKINETICS OF SINGLE DOSE SUMATRIPTAN IN HEALTHY PARTICIPANTS.

Healthy Volunteers

United States
NuPathe Inc.

Completed

Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Sumatriptan 100mg Tablets Under Fed Conditions

Healthy

India
University of Miami
Alkermes, Inc.

Recruiting

C-Cog in Early Course Schizophrenia Study

Schizophrenia

United States
Otsuka Beijing Research Institute

Completed

Aripiprazole IM Depot in the Acute Treatment of Adults With Schizophrenia

Schizophrenia

China
University of California, Los Angeles

Completed

Combination Treatment for Augmenting Language in Children With ASD (PIII)

Autism Spectrum Disorder

United States
University of Maryland, Baltimore

Terminated

Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar Disorder (PAMS)

Bipolar Disorder

United States
Northwestern University
National Alliance for Research on Schizophrenia and Depression; Pfizer

Completed

Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

United States
Fundación Marques de Valdecilla
Centro de Investigación Biomédica en Red de Salud Mental; Instituto de Investigación...

Completed

Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up (PAFIP2_3Y)

Psychotic Disorders | Schizophrenia

Spain
Fundación Marques de Valdecilla
Centro de Investigación Biomédica en Red de Salud Mental; Instituto de Investigación...

Completed

Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up (PAFIP2_nc1Y)

Psychotic Disorders | Schizophrenia

Spain
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE- EU)

Schizophrenia

Belgium, Bulgaria, Canada
Janssen-Cilag International NV

Completed

A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Psychotic Disorders | Schizophrenia

France, Poland, Germany, Spain, Slovenia, Bulgaria, Romania, Israel, Greece, Sweden, Turkey, Czech Republic, Hungary, Lithuania, Latvia, Portugal, Croatia, Slovakia, Austria, United Kingdom, Estonia, Ireland, Denmark, Saudi Arabia
Otsuka Pharmaceutical Development & Commercialization...

Completed

Aripiprazole in Adolescents With Schizophrenia (APEX 239)

Schizophrenia

United States, Puerto Rico
National Institute of Neurological Disorders and...

Terminated

PRX-00023 Therapy in Localization-Related Epilepsy

Epilepsy | Epilepsy, Temporal Lobe | Partial Epilepsy

United States
The University of Hong Kong

Recruiting

Real-life Assessment of Abilify Maintena + Rexult in Schizophrenia (MainRexult)

Anxiety Depression | Schizophrenia and Related Disorders

Hong Kong
The University of Hong Kong
North District Hospital; Queen Mary Hospital, Hong Kong

Recruiting

Substance Misuse To Psychosis for Stimulants

Schizophrenia and Related Disorders | Stimulant Dependence | Pharmacotherapy | Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis) | Stimulant Abuse

Hong Kong
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics (MAESTRO)

Schizophrenia | Antipsychotics | Long-Acting Injection | LAI | Aripiprazole

Korea, Republic of
Otsuka Pharmaceutical Development & Commercialization...

Completed

Substudy of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1) (OSMITTER)

Device Latency

United States
Otsuka Beijing Research Institute

Completed

Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder

Autistic Disorder

China
University of Copenhagen
Rigshospitalet, Denmark; UMC Utrecht; Glostrup University Hospital, Copenhagen; Copenhagen Hospital Corporation and other collaborators

Completed

Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS) (PECANS)

Schizophrenia

Denmark
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome

Schizophrenia | Schizoaffective Disorder | Metabolic Syndrome | Bipolar I Disorder

Canada
Medical University of South Carolina
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Aripiprazole Effects on Alcohol Reactivity and Consumption

Alcohol Dependence

United States
Inje University

Unknown

The New Strategy for Pharmacological Treatment in People With Schizophrenia

Schizophrenia

Korea, Republic of
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion

Schizophrenia | Major Depressive Disorder | Mental Disorder | Bipolar I Disorder

United States
VA Office of Research and Development

Withdrawn

VA Aripiprazole vs Esketamine for Treatment Resistant Depression (VAST-D II)

Depressive Disorder, Major

United States
Vanguard Research Group
Otsuka America Pharmaceutical

Completed

Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics (PRELAPSE)

Schizophrenia

United States
Otsuka Pharmaceutical Development & Commercialization...

Terminated

A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder

Schizophrenia | Major Depressive Disorder | Bipolar 1 Disorder

United States
Seoul National University Hospital
Otsuka Pharmaceutical Co., Ltd.

Completed

Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder

Major Depressive Disorder

Korea, Republic of
Wei Hao

Terminated

A Comparison of Risperidone and Aripiprazole for Treatment of Patirnts With Methamphetamine-Associated Psychosis

Methamphetamine Dependence

China
Otsuka Pharmaceutical Co., Ltd.

Completed

Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
National Taiwan University Hospital
Yu-Li Hospital; Yu-Li Veterans Hospital

Completed

Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome

Metabolic Syndrome X

Taiwan
Otsuka Pharmaceutical Co., Ltd.

Completed

Bioequivalence Between Single Administration of ASC-01 (Aripiprazole/Sertraline Combination Drug) and Concomitant Single Administration of Aripiprazole and Sertraline, and Food Effect on Pharmacokinetics of ASC-01 in Healthy Male Adults

Healthy Male Adults

Japan
KU Leuven
Universitaire Ziekenhuizen KU Leuven

Recruiting

Anti-inflammatory Effect of Pre-operative Stimulation of the Cholinergic Anti-Inflammatory Pathway

Postoperative Ileus

Belgium
Chimei Medical Center

Completed

Compare the Efficacy and Tolerability of the Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitors (SSRIs) Used in Major Depression

Major Depressive Disorder

Taiwan
Roxane Laboratories

Completed

Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fed Conditions

Migraine

United States
Cady, Roger, M.D.
GlaxoSmithKline; Clinvest

Terminated

Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction

Post Traumatic Headache

United States
Sanofi

Completed

XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy

Colorectal Neoplasms | Colorectal Carcinoma | Metastases
Central South University

Recruiting

Using 18F-FPEB PET to Identify mGLUR5 Availability in Affective Disorders

Bipolar Disorder | Major Depressive Disorder

China
Takeda

Completed

Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder

Major Depressive Disorder

Japan
H. Lundbeck A/S
Alder Biopharmaceuticals, Inc.

Completed

Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman

Migraine

Australia
GlaxoSmithKline

Completed

Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet

Migraine Disorders
Washington University School of Medicine
Takeda; Queen's University

Completed

Remediation of Age-related Cognitive Decline: Vortioxetine and Cognitive Training (BBS)

Age-related Cognitive Decline

United States
H. Lundbeck A/S

Completed

A Study Investigating Formulations of Vortioxetine Applied Under the Tongue in Healthy Subjects

Healthy

United Kingdom
H. Lundbeck A/S

Completed

Open-label Safety Extension Study of 15 and 20 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults

Major Depressive Disorder
Centre Hospitalier St Anne

Not yet recruiting

Prediction of the Therapeutic Response in Depression Based on Neuro-computational Modeling Assessment of Motivation (STRATIDEP)

Major Depressive Disorder

France

Search clinical trials for: Serotonin 5-HT4 Receptor Agonists

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations